Genmab's Q4 2024 results impress with $897.4M revenue and 29% growth. GMAB's balance sheet is strong with nearly $3 billion ...

Gilead Sciences is rated a Strong Buy due to strong Q4 2024 results and a robust HIV franchise. Check out my 12-month price ...

This important study presents compelling observational data supporting a role for transcription and polysome accumulation in the separation of newly replicated bacterial chromosomes. The study is ...

The program integrates Owkin’s expertise in AI-driven indication selection, external control arms (digital twins) for early anti-tumor activity insights in Phase I, and biomarker-led patient ...

However, the role and mechanism of iron in the phase of enteritis and the subsequent repairing phase of intestinal stem cells has not been elucidated ... culture enteroids using IntestiCult™ Organoid ...

The government is proposing to ease restrictions on how some pension schemes are managed, as part of efforts to boost economic growth. The Treasury said defined benefit pension schemes have a ...

Wall Street analysts have set lofty price targets in anticipation of further sales growth. Iovance Biotherapeutics ... in batches of one from immune cells called tumor-infiltrating lymphocytes ...

Exploratory study of TAS-102 combined with intermittent administration of fruquintinib in the treatment of third-line metastatic colorectal cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...

Despite severe differences regarding the total number of cells, cell cycle phase distribution and expression of some cell cycle relevant genes showed similar patterns under continuous and short-term ...

Biological and Chemical Research Centre, Faculty of Chemistry, University of Warsaw, Z. wirki i Wigury 101, 02-089 Warszawa, Poland ...

China is firmly entrenched in a "medium growth" phase as its economy transitions into a more mature state, and its GDP will likely grow around 5 percent this year and beyond, said Joe Ngai ...